The CFTC draws a line on self-certification
The CFTC’s letters to Novig and ProphetX put a practical limit on how far prediction market exchanges can test sports contracts through self-certification. Both firms had certified new products for listing, but the agency asked them to hold off and explain how the contracts comply with federal commodities law. The exchange-led process is meant to let products reach the market without a prior agency approval step; these letters show that the CFTC can still intervene before a proposed contract becomes available to customers.
A CFTC spokesperson confirmed the letters and said, “Any derivatives contract offered by a CFTC-regulated exchange must be compliant with the Commodity Exchange Act.” Neither product had gone live, so customers haven’t traded them. That timing matters: the dispute is about whether the contracts can be listed, rather than how the agency might treat trading that has already taken place.
Two contracts, different objections
Novig’s proposed micro contracts included bets on which player scores first in a basketball game. The CFTC raised concerns that these markets could be manipulated. A wager tied to one event within a game leaves a narrower outcome to influence than a market on the final result, which helps explain why a single-play contract can attract closer scrutiny. The agency’s concern, as described, is about the contract’s susceptibility to manipulation; the letters’ existence doesn’t by itself establish that manipulation has occurred.
ProphetX’s Scorigami contracts would pay out based on whether a game ends with a scoreline never previously recorded in that sport. The agency questioned whether those contracts fit the Commodity Exchange Act’s definition of a swap. That’s a different kind of challenge from Novig’s: it goes to how the product is characterized under the statute, not simply to whether an outcome might be manipulated. The distinction could matter to other exchanges considering products that turn unusual sports outcomes into tradable contracts.
People familiar with the letters described the firms’ filings as false self-certifications, a term for certifying contracts that may not be allowed under the statute. ProphetX said the agency’s staff asked it to pause listing while they review the products. A company spokesperson said staff “requested that we voluntarily defer listing the Scorigami contracts pending further review, not that we withdraw them.” ProphetX said it has supplied more analysis about compliance and economic purpose, and remains in contact with the CFTC. Novig didn’t immediately respond to a request for comment.
What the process means for other exchanges
The current process lets exchanges self-certify contracts and list them without advance approval, leaving the CFTC able to intervene afterward. In practice, a request to defer a launch can create a meaningful pause even when the exchange’s filing has already been made. The agency didn’t say whether it has previously asked an exchange to delay a self-certified sports contract. One source characterized the letters as “kind of a warning shot” to the sector. This is more significant than it looks: the letters put exchanges on notice that submitting a certification may not settle whether a product can proceed.
The scrutiny may reach beyond Novig and ProphetX. Senior CFTC officials have also spoken with DraftKings and FanDuel, warning that micro contracts could prompt a similar response. Some exchanges have criticized the agency’s position, noting that state regulators allow comparable in-game wagers at licensed sportsbooks. That argument highlights a jurisdictional tension, but it doesn’t resolve the federal question raised by contracts offered on CFTC-regulated exchanges.
The letters follow CFTC inquiries last month into incentive programs at Kalshi, Polymarket, Rothera and Novig. They also arrive as the agency prepares a final rule after proposing restrictions in June. Its 267-page proposal would limit in-game props and markets on high school sports. The proposal and these contract reviews are separate developments, though both show the agency examining how sports-related products fit within its authority. The broader dispute over how federal rules apply to sports contracts continues, with several states arguing that these products belong under gambling law.
League rules add pressure
Professional leagues have objected to the same kinds of single-play markets at the center of the CFTC’s letters. On October 19, the NBA tightened restrictions on player props and micro bets offered by its sportsbook partners, including wagers on who scores the first basket. Yogonet reported on the change. Those league rules apply to traditional sportsbooks, not prediction markets. Still, they show that concern about wagers tied to individual plays isn’t confined to federal regulators.
There’s a limit to what that comparison tells us. A league’s rules for its sportsbook partners don’t determine whether a prediction market contract complies with federal commodities law, and the article provides no indication that the NBA’s restrictions prompted the CFTC’s letters. But the overlap in the types of bets under scrutiny gives exchanges a wider set of concerns to consider as they decide whether a proposed product is worth pursuing.
What happens next
The CFTC hasn’t said what it would do if either exchange listed the contracts anyway. For now, Novig and ProphetX can make their case to agency staff, and their exchanges’ next steps may show how much room the market has for single-play sports products before the final rule arrives. If you’re working in this space, the immediate question is how much uncertainty a self-certification leaves an exchange carrying when agency staff ask for a pause.
Sports already drive most activity on the largest platforms, with NFL trading volume offering one view of that demand. The commercial appeal is clear, but demand alone won’t answer the agency’s questions about contract structure, compliance or economic purpose. And this is the part most people overlook: a product can attract users and still face a difficult path to listing if regulators dispute what it is or how it could be influenced. For now, the outcome is unsettled. More review ahead.